DUBLIN--(BUSINESS WIRE)--The "Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions, Application, Companies" report has been added to ResearchAndMarkets.com's offering.
Global biopsy device market is anticipated to surpass USD 2.8 Billion by the year end of 2025.
This report captures a detailed analysis of global Biopsy Devices market and volume and provides an all-encompassing analysis of the key growth drivers and preventive factors, key players and their projections for the future.
The main factor that fuel the market growth is minimal invasive surgical procedure which mitigate the complications and side-effects and proliferating the biopsy device. Increasing private funding for cancer research, government expenditure on healthcare across the world, rising technological up-gradation and favorable reimbursement policies will further propel the global biopsy device market in coming future.
As per world cancer report by the end of year 2020 there will be 15 Million new cancer cases. The rising prevalence of cancer disease across the world like breast cancer, lung cancer, prostate cancer etc will drive the market of biopsy devices. These days, people are more health conscious and they are shifting towards minimal invasive technique over conventional technique to ensure complete safety.
Biopsy Needle is One of the Significant Segments in the Global Biopsy Device Market
In this report, we have done comprehensive analysis of different types of Biopsy Device product. By biopsy device product, the market is categorized into 4 parts; Biopsy Needle, Guidance system segment, Biopsy Guns, Reagents and kits in which Biopsy needle is one of the most significant segment in global biopsy device market.
- Biopsy Needle segmented into two parts; Fine Aspiration Needles and Core Needle.
- Guidance system is further categorized into three parts; Ultrasound-guided, Stereotactic-guided and Clinically guided.
- Ultrasound-guided is the major segment among guidance system, where ultrasound is done to identify the abnormalities and then use needle to take sample of tissues from that particular places and this whole process takes 30 minutes.
Besides, this report also discusses about the market of Guidance system, say for instance (Clinically-guided, Stereotactic-guided, Ultrasound-guided) and Reagents & kits system. The above mentioned markets of devices make a great impact on this market due to inclination on minimally invasive surgeries as well as rising prevalence of cancer's like Prostate, Breast and Lungs.
Breast Biopsy is the Largest Application in the Global Biopsy Device Market
In this report, we have fragmented the global biopsy device market on the basis of application into three parts; Breast Biopsy, Lung Biopsy and Prostate Biopsy. The prevalence of breast cancer and prostate cancer across the world is rising at the rapid pace and demand of minimally invasive surgeries among the people is also rising and hence it will further propel the market growth of global biopsy device. In this report, breast biopsy alone dominated the biopsy device market.
Asia-Pacific Will Be One of the Fastest Growing Markets for Biopsy Devices, Globally
In this report, we have done complete insight on regional analysis of global biopsy device market. We have categorized the market into four regional front; North America, Europe, Asia-Pacific and Rest of the world. Asia-Pacific will be one of the fastest growing markets for biopsy device.
Key Topics Covered
2. Research Methodology
3. Executive Summery
4. Global - Biopsy Devices Market
5. Market Share - Global Biopsy Devices
5.1 By Product
5.2 By Application
5.3 By Region
5.4 By End-User
6. By Product - Biopsy Devices Market
6.1 Biopsy Needles
6.1.1 Fine Aspiration Needles
6.1.2 Core Needles
6.2 Guidance Systems
6.3 Biopsy Guns
6.4 Reagents and kits
6.5 Others (Brushes, Curettes and Punches etc)
7. By Application - Biopsy Devices Market
7.1 Breast Biopsy
7.2 Lung Biopsy
7.3 Prostate Biopsy
8. By Region - Biopsy Devices Market
8.1 North America
8.4 Rest of World
9. By End-User - Biopsy Devices Market
9.1 Diagnostic Center
9.4 C. R. Bard, Inc. - Company Analysis
9.6 Merger & Acquisition
9.7 Financial Insight
10. Becton, Dickinson and Company - Company Analysis
10.2 Key Developments
10.3 Merger & Acquisition
10.4 Financial Insight
11. B. Braun Melsungen AG - Company Analysis
11.2 Key Developments
11.3 Merger & Acquisition
11.4 Financial Insight
12. Cardinal Health, Inc. - Company Analysis
12.2 Key Developments
12.3 Merger & Acquisition
12.4 Financial Insight
13. Olympus Corporation - Company Analysis
13.2 Key Developments
13.3 Merger & Acquisition
13.4 Financial Insight
14. Boston Scientific Corporation - Company Analysis
14.2 Key Developments
14.3 Merger & Acquisition
14.4 Financial Insight
15. Medtronic plc - Company Analysis
15.2 Key Developments
15.3 Merger & Acquisition
15.4 Financial Insight
16. Hologic, Inc. - Company Analysis
16.2 Key Developments
16.3 Merger & Acquisition
16.4 Financial Insight
17. Growth Drivers
17.1 Inadequate Screening Tests for Particular Cancers
17.2 Demand for Minimally-Invasive Biopsy Technique
17.3 Advancement in Biopsy Techniques
17.3.1 Point A
17.3.2 Point B
17.3.3 Point C
17.3.4 Point D
17.3.5 Point E
18.1 Breast Biopsy Reimbursement Bundling
18.2 Biopsy Limitations
For more information about this report visit https://www.researchandmarkets.com/r/ht17dn